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Exposure of human skin in vivo to UVB radiation induces 
pyrimidine dimers in DNA and alters the morphology and 
function of epidermal Langerhans cells. Cells in human skin 
have been reported to contain a photoreactivation repair 
mechanism that, following exposure to UV A or visible light, 
repairs UVB-induced pyrimidine dimers. The purpose of this 
study was to determine whether exposure to photoreactivat-
ing light would also reverse the UVB-induced morphologic 
alterations in human Langerhans cells. The skin of eight 
healthy volunteers was exposed to a low dose ofUVB radia-
tion (between 0.75 and 1.5 times the minimal erythema 
dose), and immediately thereafter exposed to photoreactivat-
ing light from either BLB fluorescent lamps (UV A radiation) 
D NA within cells of the epidermis is highly suscepti-ble to damage from the UVB radiation present in sunlight. These wavelengths ofUV radiation cause several structural alterations in DNA, including the formation of pyrimidine dimers, 6-4 photoprod-
ucts, and single-strand breaks [1]. In mammalian cells, these lesions 
in DNA are repaired by a variety of mechanisms, including excision 
repair, post-replication repair, and photoreactivation repair [2]. 
Photoreactivation repair has been studied most extensively with 
cells from marsupials. Such cells have been shown to contain an 
enzyme that, when activated by UVA or visible light, splits UV-
induced pyrimidine dimers, thereby restoring the integrity of the 
DNA strand [3]. This photoreactivation repair mechanism has ex-
quisite specificity for pyri~idine dimers and ~here.fo~e c~n be used to 
determine whether a particular effect ofUV irradiatwn mvolves the 
formation of pyrimidine dimers. . . . 
Recently, this approach was used to.iden~lfy t~1e molecular leswns 
involved in the UVB-induced alterations m epidermal Langerhans 
cells. Exposure of the skin to UVB radiation produces morph~logic 
and functional alterations in Langerhans cells that correlate With an 
impairment in the induction ~f COil; tact allergy to hap tens applied to 
the site of irradiation [4] . Studtes wtth the South Amencan opossum 
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ATPase: adenosine triphosphatase 
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or i.nc~ndescent bulbs (visible light). After exposure to~ 
rad1at1on, the number of ATPase+ epidermal Langerha~ 
cells _was r.educ~d in al~ subjects to be~~en 21% and 6~% 0! 
that m umrrad1ated sbn, and the maJonty of the remamin 
cells ~xhib.ited morphologic alterations. Exposure of th~ 
UVB-mad1ated skin to photoreactivating light did not re, 
verse or reduce these effects. We conclude that UVB 
induced m~rphologic alterat~ons. of human Langer~ans cell~ 
are not subject to photoreacttVatlOn. These results 1mply ei 
ther that.pyri~i.dine dimers are not involved in these effec~ 
ofUVB 1rrad1atwn, or that photoreactivation does not occ~ 
in human Langerhans cells in situ.] Invest Dermato/95:144 
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Monodelphis domestica, whose cells contain photoreactivating en, 
zyme, demonstrated that the morphologic and functional alter, 
ations induced in Langerhans cells by UVB radiation could be r~ 
versed by exposure to rhotoreactivating light [5]. 
Photoreactivation o pyrimidine dimers has also been reported tQ 
occur in human skin following exposure to wavelengths in th~ 
range of 320 to 600 nm [6-8]. In addition, a photoreactivarin& 
enzyme has been isolated recently from human tissue [9] . We wer~ 
therefore interested in determining whether the UVB-induced a], 
terations of Langerhans cells in human skin were also subject tQ 
photoreactivation repair. In these studies, we exposed the skin o~ 
normal volunteers to UVB radiation from FS40 sunlamps in dose~ 
sufficient to reduce the number of ATPase+ Langerhans cells an~ 
produce morphologic alterations in many of the remaining cells. 
We then attempted to reverse these effects by immediately exposing 
the UVB- irradiated skin to doses of UV A or visible light shown to 
be capable of photoreactivating pyrimidine dimers in marsupial and 
human skin, respectively. 
MATERIALS AND METHODS 
Subjects Eight adult female volunteers (age range, 19-50 yean) 
participated in the study, after giving informed consent. 
Radiation Sources UVB radiation was provided by two FS40 
sunlamps (National Biological Corp., Twinsburg, OH) that emit a 
continuous spectrum between 280 and 400 nm. Approximately 
60% of the energy is emitted in the UVB range from 280 to 320 run, 
with a peak emission at 313 nm. The dose rate was 12 W /m2• 
Photoreactivating light of wavelengths in the UVA region was 
obtained from two General Electric BLB fluorescent lamps filtered 
through 3 mm of window glass to remove wavelengths below 320 
nm. The dose rate of the filtered BLB source was 10 W /m2• Visible 
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light (> 400 nm) was obtained from a 25-W incandescent bulb at a 
distance of20 em (dose rate, 4.8 W jm2). All radiation sources were 
monitored with a calibrated 742 spectroradiometer (Optronics Lab-
oratories, Inc., Orlando, FL), which measures the spectral emission 
at 1-nm intervals and integrates the emitted energies over the entire 
emission spectrum of the lamps. 
Experimental Design 
Day 1: Subjects were irradiated for determination of their minimal 
erythema dose (MED). The inner surface of the right forearm was 
irradiated with graded doses ofUVB radiation starting at 1200 J/m2 
and increasing in 25% increments. 
Day 2: The MED was defined as the first visible erythema 24 h 
after exposure to UVB radiation. Then, the left forearm was cov-
ered with aluminum foil and the patients were irradiated with UVB 
through two holes 1.5 em in diameter. Immediately thereafter, one 
of the UVB-irradiated sites was shielded, and the other was given 
photoreactivating light for 90 min (54 kJ/m2) from a fi ltered BLB 
source or photoreactivating light for 40 min (11.4 kJ/m2) from the 
incandescent bulb. These doses of photoreactivating light were used 
because they were effective in opossum (in that case UV A) and 
humans (5,6]. Areas that received UVB alone, photoreactivating 
light alone, or no irradiation at all served as control sites. During the 
experiment, the light source was covered with black cloth to elimi-
nate daylight, and the experimental room was not illuminated. At 
the end of the irradiation, the exposed and unexposed sites were 
covered with aluminum foil and opaque tape for 24 h. 
Day 3: The exposed and unexposed sites were uncovered and im-
mediately anesthesized with 1% lidocaine. Shave biopsies were per-
formed with a· razor blade, and the samples were placed in a 0.9% 
sodium chloride solution, shielded from light, and prepared for 
A TPase staining. 
Staining for Lattgerhans Cells: The epidermis was separated from 
the dermis after a 2.5-h incubation at 37°C in buffered ethylenedin-
itro tetraacetic acid. The epidermal sheets were fixed overnight at 
4 oc in 0.05 M cacodylate-2% paraformaldehyde solution. After 
fixation, the samples were washed 3 times with saline and incubated 
at 37°C for 45 min in a solution containing ATP powder, Tris-Mal, 
MgS04, and Pb(N03h. The samples were then washed again in 
saline and immersed for 60 sec in NH2S solution. The stained speci-
mens were mounted in glycerol phosphate-buffered saline (PBS) on 
glass slides, and the number of dendritic ATPase+ cellsjmm2 epi-
dermis was determined by counting the cells under a Nikon Opti-
phot microscope (Nikon Inc., Garden City, NY). Between 10 and 
20 fields from each biopsy were counted at X400 magnification 
using a WHK 10 X 20 L optical grid (Olympus Optical Co., 
Tokyo, Japan). 
RESULTS 
The skin types and MED of the study population are given in T able 
I. For the photoreactivation experiment, it was necessary to give a 
dose ofUVB radiation small enough to avoid extensive damage to 
DNA but large enough to alter Langerhans cells. All subjects were 
given between 0.75 and 1.5 MED, with the majority receiving 1.0 
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Table I. The MED of the Study Population 

























' Minimal eryth ema dose, defined by graded doses of radiation from 2 FS-40 sun-
lamps. 
in all subjects at 24 h after UV irradiation (Tables II and III). Mor-
phologic alterations, characterized by loss of dendrites and constric-
tion of the cell body, were observed in the majority of the remaining 
A TPase+ cells. These changes in Langer hans cells were not reversed 
or reduced by exposure to UVA (Table II) or visible (Table III) light 
immediately after the UVB irradiation. We did not notice any 
change in UVB-induced erythema following exposure to photo-
reactivating light. 
DISCUSSION 
Photoreactivation repair has been used to determine whether py-
rimidine dimers in DNA are involved in photobiologic responses. 
This approach is possible because of the specificity of the photoreac-
tivating enzyme for these particular lesions in DNA. Recent studies 
in the opossum have demonstrated that both the morphologic alter-
ations in epidermal Langer hans cells and the impairment of immu-
nologic function by UVB radiation (10] are largely attributable to 
these photoproducts in DNA. Using the same conditions for pho-
toreactivation, we were unable to demonstrate any reversal of the 
effects of UVB radiation on Langerhans cells in human skin. In 
addition, we attempted to photoreactivate the UVB-induced alter-
ations in Langerhans cells using visible light under conditions in 
which photoreactivation of pyrimidine dimers in human skin was 
demonstrated (6] . This attempt was also unsuccessful. 
It is possible that photoreactivation of damage to Langer hans cells 
might have occurred had we used higher doses of UVA or visible 
light or a different waveband of radiation. However, this seems 
unlikely based on the ability of the radiation sources and doses we 
used to cause photoreactivation in other systems. Two other possi-
bl'e interpretations of our results remain, namely, that pyrimidine 
dimers are not involved in the effects ofUVB radiation on Langer-
barrs cells in human skin or that the cellular target of the UVB 
radiation lacks photoreactivating enzyme. The first possibility is 
contrary to the. results m the opossum, 111 which pyrimidine dimer 
formation was responsible for the effects ofUVB radiation on Lan-
gerhans cells. Although human and opossum skin clearly differ in 
many characteristics, the morphologic responses of Langerhans 
cells t~ UVB radiation a.:e identical. It seems unlikely that a differ-
ent lesiOn m DNA or a dtfferent target molecule would be involved 
in the response of human Langerhans cells to UVB radiation, but 
our experiments cannot rule out this possibility. The second possi-
bility, that the target cells lack the ability to carry out photoreactiva-
Table II. Effect of Ultraviolet A on the Number of Langerhans Cells in UVB-Irradiated Skin 
Subject UVB Dose Unexposed' UVB' %Decrease UVB/ PRL•·1 %Decrease 
1 1.5 X MED 986 ± 33 473 ± 41 52J 501 ± 26 49J,, 
2 1 X MED 863 ± 27 298 ± 26 65J 253 ± 24 71J,< 
3 1 X MED 967 ± 44 536 ± 37 45J 528 ±50 45J,, 
4 0.75 X MED 948 ± 31 748 ± 28 21J 684 ± 41 28J,, 
•Number of ATPase+ Langerhans cells/ nun2 (mea n ± SEM). 
'Photoreactivating light (PRL) was given for 90 min (54 kJ/m2) from BLB fluorescent lamps immediately after UVB-irradiation. 
' Photoreactivating light only. 
"p < 0.05 (probabiliry of no difference between unexposed and exposed skin determined by Student t rest). 
•No statistically significant difference was found between UVB/PRL and UVB groups. 
PRL'·' %Decrease 
987 ± 32 0 
727 ± 33 16J 
1065 ± 27 0 
922 ± 22 3 
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Table ill. Effect of Visible Light on the Number of Langer hans Cells in UVB-Irradiated Skin 
Subject UVB Dose Unexposed• UVB• %Decrease UVB/PRL'·b %Decrease PRL"·' o/o Decrease 
1 lXMED 885 ± 37 473 ± 36 47' 477 ± 37 46'·' 821 ± 34 7 
2 1 XMED 1077 ± 45 600 ±52 44' 730± 48 33'·' 1094± 44 0 
3 1 XMED 862 ± 29 437 ± 28 49' 512 ± 29 40'·' 847 ±58 2 
4 1 XMED 1255 ±58 620 ±55 51' 538 ± 43 57'·' 1227 ± 43 2 
•Number of ATPase+ Langerhans cells/mm2 (mean± SEM). 
'Photoreactivating light (PRL) was given for 40 min (11.4 kJ/m2) from a 25-W incandescent bulb immediately after UVB radiation. 
'Photoreactivating light only. 
'p < 0.05 (probability of no difference between unexposed and exposed skin determined by Srudent t test). 
'No statistically significant difference was found berween UVB/PRL and UVB groups. 
tion repair, seems to be a more plausible interpretation of our results. 
Although photoreactivating enzyme has recently been isolated 
from neonatal human tissue [9}, its existence in all cells of the adult 
epidermis has not been established. For example, photoreactivation 
could not be demonstrated in cultures of adult fibroblasts treated 
with UVA radiation [11). In a murine system, photoreactivation 
repair could be demonstrated in neonatal epidermal cells, but not in 
epidermal cells of adult mice or in dermal fibroblasts of neonates or 
adults (12). Therefore, it is conceivable that human Langer hans cells 
(assuming that these cells are the direct target of the UVB radiation) 
may lack a photoreactivation mechanism, even though such a 
mechanism is operative in other cells in the epidermis. Direct mea-
surements of pyrimidine dimers in purified cell populations will be 
required to resolve this issue. 
We thank Dr. Lee Am1 Applegate for her assista11ce a11d Ms. Dominique De Vies for 
preparing the mattuscript. 
REFERENCES 
1. Peak MJ, PeakJG: Solar-ultraviolet-induced damage to DNA. Photo-
dermatology 6:1-15, 1989 
2. Hanawalt PC, Liu SC, Parsons S: DNA repair responses in human skin 
cells. J Invest Dermatol 77:86-90, 1981 
3. Ley R: Photoreactivation ofUV-induced pyrimidine dimers and ery-
thema in the marsupial Monodelphis domestica. Proc Nat! Acad Sci 
USA 82:2409-2411, 1985 
4. Toews GB, Bergstresser PR, Streilein JW: Epidermal Langer hans cell 
densiry determines whether contact hypersensitivity or unrespon-
siveness follows skin painting with DNFB. J Immunol 124:445 -
453, 1980 
5. LeVee GJ, Applegate LA, Ley RD: Photoreversal of the ultraviolet 
radiation-induced disappearance of ATPase-positive Langerhans 
cells in the epidermis of Monodelphis domestica. J Leuk Biol 
44:508-513, 1988 
6. Sutherland BM, Harber LC, Kochevar IE: Pyrimidine. dimer forma-
tion and repair in human skin. Cancer Res 40:3181-3185 , 1980 
7. D'Ambrosio SM, Whetstone JW, Slazinski L, Lowney E: Photorepait 
of pyrimidine dimers in human skin in vivo. Photochem Photobiol 
34:461-464, 1981 
8. Eggset. G, Volden G, Krokan H: UV-induced DNA damage and its 
repa1r m human skmm vivo studied by sensirive immunohistochezn-
ical methods. Carcinogenesis 4:745-750, 1983 
9. Ogut SE, D'Ambrosio SM, Samuel M, Sutherland BM: DNA photo-
reacuvatmg enzyme from human tissues. J Photochem Photobiol 
(Biology) 4:47-56, 1989 
10. Applegate LA, Ley RD, Alcalay-J, Kripke ML: Identification of the 
molecular target for the suppression of contact hypersensitivity by 
ultraviolet radiation. J Exp Med 170:1117-1131, 1989 
11. Tanew A, Honigsman H, Stampf S, Jerney W: UVA does not photo-
, reactivate pyrimidine dimers in cultured human fibroblasts (abstr) . 1 
Invest Dermatol 92:528, 1989 
12. Ananthaswamy HN, Fisher MS: Photoreactivation of ultraviolet radi-
ation-induced pyrimidine dimers in neonatal BALB/c mouse skin. 
Cancer Res 41:1829-1833, 1981 
